Eurobio Scientific SA (ALERS) — Net Asset Quality Index
Eurobio Scientific SA (ALERS) has a Net Asset Quality Index of 69.8% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €259.11 Million minus total liabilities of €78.26 Million yields net assets of €180.85 Million. A higher index indicates a stronger, lower-leverage balance sheet. See how many days can Eurobio Scientific SA fund operations to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Eurobio Scientific SA Net Asset Quality Index Over Time (2007–2024)
This chart shows how Eurobio Scientific SA's Net Asset Quality Index has evolved across 18 annual periods from 2007 to 2024. As of June 2025, the index stands at 69.8%, representing net assets of €180.85 Million against total assets of €259.11 Million EUR. Explore ALERS cash generation efficiency to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Eurobio Scientific SA (2007–2024)
The table below presents the year-by-year Net Asset Quality Index for Eurobio Scientific SA from 2007 to 2024, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see ALERS stock market capitalisation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 69.5% | €178.85 Million | €257.17 Million | €78.31 Million | ▲ +14.2 pp |
| 2023 | 55.4% | €175.17 Million | €316.33 Million | €141.16 Million | ▲ +3.1 pp |
| 2022 | 52.3% | €172.67 Million | €330.42 Million | €157.75 Million | ▼ -24.3 pp |
| 2021 | 76.6% | €160.22 Million | €209.22 Million | €49.00 Million | ▲ +14.0 pp |
| 2020 | 62.6% | €107.84 Million | €172.30 Million | €64.45 Million | ▲ +17.5 pp |
| 2019 | 45.1% | €36.56 Million | €81.01 Million | €44.44 Million | ▲ +2.8 pp |
| 2018 | 42.4% | €29.62 Million | €69.90 Million | €40.27 Million | ▼ -1.9 pp |
| 2017 | 44.3% | €31.69 Million | €71.57 Million | €39.88 Million | ▲ +5.9 pp |
| 2016 | 38.3% | €12.23 Million | €31.89 Million | €19.66 Million | ▼ -26.9 pp |
| 2015 | 65.3% | €23.31 Million | €35.71 Million | €12.40 Million | ▼ -3.7 pp |
| 2014 | 69.0% | €27.95 Million | €40.50 Million | €12.55 Million | ▲ +7.5 pp |
| 2013 | 61.5% | €20.56 Million | €33.41 Million | €12.85 Million | ▼ -2.1 pp |
| 2012 | 63.6% | €24.50 Million | €38.49 Million | €13.99 Million | ▼ -13.4 pp |
| 2011 | 77.1% | €13.57 Million | €17.60 Million | €4.04 Million | ▲ +15.7 pp |
| 2010 | 61.4% | €19.19 Million | €31.26 Million | €12.07 Million | ▼ -8.3 pp |
| 2009 | 69.7% | €25.46 Million | €36.55 Million | €11.09 Million | ▲ +37.0 pp |
| 2008 | 32.6% | €9.74 Million | €29.85 Million | €20.11 Million | ▼ -15.4 pp |
| 2007 | 48.1% | €18.07 Million | €37.59 Million | €19.52 Million | — |